Impact of cone-beam computed tomography for the identification and management of an oral portal of entry in patients with infective endocarditis. A Delphi study.


Journal

Medicina oral, patologia oral y cirugia bucal
ISSN: 1698-6946
Titre abrégé: Med Oral Patol Oral Cir Bucal
Pays: Spain
ID NLM: 101231694

Informations de publication

Date de publication:
01 Jan 2022
Historique:
received: 18 05 2021
accepted: 06 09 2021
pubmed: 27 9 2021
medline: 31 12 2021
entrez: 26 9 2021
Statut: epublish

Résumé

Infective endocarditis (IE) is a rare and life-threatening disease. Cutaneous portal of entry (POE) is predominant for IE, but an oral POE is the second most frequent source. Thus looking for and treating an oral POE in IE patients is of critical importance in order to reduce the risk of IE relapse or recurrence. The objectives of this study were: 1) To reach a consensus on decision-making following the detection of an oral POE on cone-beam computed tomography (CBCT) while they were not identified using the current recommended approach in IE patients (oral examination and orthopantomogram: OPT). 2) To determine whether this consensus differs when regarding the microbiology of IE. Twenty oral or maxillofacial surgeons participated to this Delphi study. The questionnaire was based on five radiological cases (OPT and matching CBCT) with two scenarios according to the objectives of detecting oral POE in an IE patient (curative in case of oral causative microorganism, and preventive if not) and different therapeutic approaches (surgical or conservative treatment, no treatment) for each of them. Consensus was defined as an agreement rate of ≥75%. The response rate was≥85%. After four rounds, consensus was achieved for all proposals. CBCT changed the decision-making of experts in four cases. In one case, the decision was influenced by the IE microbiology toward a more radical approach in case of oral causative microorganism. In IE patients, CBCT changed markedly the decision-making of experts by eradicating more oral POE than when using OPT. This could reduce the risk of IE relapse and recurrence.

Sections du résumé

BACKGROUND BACKGROUND
Infective endocarditis (IE) is a rare and life-threatening disease. Cutaneous portal of entry (POE) is predominant for IE, but an oral POE is the second most frequent source. Thus looking for and treating an oral POE in IE patients is of critical importance in order to reduce the risk of IE relapse or recurrence. The objectives of this study were: 1) To reach a consensus on decision-making following the detection of an oral POE on cone-beam computed tomography (CBCT) while they were not identified using the current recommended approach in IE patients (oral examination and orthopantomogram: OPT). 2) To determine whether this consensus differs when regarding the microbiology of IE.
MATERIAL AND METHODS METHODS
Twenty oral or maxillofacial surgeons participated to this Delphi study. The questionnaire was based on five radiological cases (OPT and matching CBCT) with two scenarios according to the objectives of detecting oral POE in an IE patient (curative in case of oral causative microorganism, and preventive if not) and different therapeutic approaches (surgical or conservative treatment, no treatment) for each of them. Consensus was defined as an agreement rate of ≥75%.
RESULTS RESULTS
The response rate was≥85%. After four rounds, consensus was achieved for all proposals. CBCT changed the decision-making of experts in four cases. In one case, the decision was influenced by the IE microbiology toward a more radical approach in case of oral causative microorganism.
CONCLUSIONS CONCLUSIONS
In IE patients, CBCT changed markedly the decision-making of experts by eradicating more oral POE than when using OPT. This could reduce the risk of IE relapse and recurrence.

Identifiants

pubmed: 34564684
pii: 24885
doi: 10.4317/medoral.24885
pmc: PMC8719786
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e42-e50

Références

Arch Cardiovasc Dis. 2017 Aug - Sep;110(8-9):482-494
pubmed: 28629781
J Am Coll Cardiol. 2016 Jan 19;67(2):151-158
pubmed: 26791061
JAMA Netw Open. 2018 Jun 1;1(2):e180281
pubmed: 30646073
Med Decis Making. 1991 Apr-Jun;11(2):88-94
pubmed: 1907710
Eur J Orthod. 2011 Aug;33(4):344-9
pubmed: 21131389
J Am Coll Cardiol. 2012 May 29;59(22):1968-76
pubmed: 22624837
Clin Radiol. 2020 Sep;75(9):647-657
pubmed: 32451060
J Endod. 2017 Feb;43(2):194-199
pubmed: 28132707
Dentomaxillofac Radiol. 2014;43(4):20130137
pubmed: 24766060
Clin Infect Dis. 2012 May;54(9):1230-9
pubmed: 22492317
Clin Infect Dis. 2017 Jun 15;64(12):1678-1685
pubmed: 28369398
Palliat Med. 2017 Sep;31(8):684-706
pubmed: 28190381
Dentomaxillofac Radiol. 2016;45(5):20150391
pubmed: 26985980
J Am Dent Assoc. 2012 Aug;143(8):899-902
pubmed: 22855905
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jan;129(1):21-26
pubmed: 31227459
Dentomaxillofac Radiol. 2015;44(1):20140197
pubmed: 25224586
Circulation. 2015 Oct 13;132(15):1435-86
pubmed: 26373316
Clin Microbiol Infect. 2014 Jun;20(6):566-75
pubmed: 24102907
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Rev Stomatol Chir Maxillofac Chir Orale. 2013 Apr;114(2):116-8
pubmed: 23838254
J Endod. 2016 Mar;42(3):356-64
pubmed: 26902914

Auteurs

A Cloitre (A)

Faculty of Dentistry,1 place Alexis Ricordeau 44042 Nantes, France alexandra.cloitre@univ-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH